Biosimilar-Substitution Restrictions Head To Pa. Senate
A Pennsylvania Senate committee on Wednesday advanced legislation that would restrict substitution of biosimilars for their brand-name counterparts, one of many comparable bills that are moving through statehouses across the country...To view the full article, register now.
Already a subscriber? Click here to view full article